PO.CL02.01 · 临床研究
Biostatistics in Clinical Trials / Surgical Oncology
-
-
-
- 6437 6437 辅助CDK4/6抑制剂在早期乳腺癌中的疗效比较：一项使用NetMetaEasy平台的基于风险比的网状Meta分析 Comparative efficacy of adjuvant CDK4/6 inhibitors in early breast cancer: A hazard ratio-based network meta-analysis using the NetMetaEasy platform Janos Tibor Fekete, Balazs Gyorffy
- 6438 6438 未完的故事：黑色素瘤临床试验中止与未发表的后果 Unfinished stories: Consequences of melanoma clinical trial discontinuation and non-publication Hadeer Hafez, Abdelrahman Hagag, Mohamed Ashraf Mohamed, Mohamed Saad Rakab, Ismail Zakaria Ismail, Aya Jamal Elkenani, Nada Elmetwally Ahmed, Abdelrahman M. Hafez, Doaa Mashaly, Ali Tarek Lasheen, Mohamed Abdelsalam
- 6439 6439 增长最快病灶的生长速率比RECIST 1.1直径总和的生长速率更能预测生存：一项对84例NSCLC患者多线治疗的真实世界回顾性研究 Growth rate of fastest-growing lesion predicts survival better than growth rate of RECIST 1.1 sum of diameters: A real-world retrospective study of 84 NSCLC patients over multiple treatment lines Dean C. Bottino, Jayant Narang, Michael Hanley, Maria Guzman Castillo, Heidi Loponen, Risto Kesavuori, Juha Mehtala, Mark Lin
-
-
- 6442 6442 微创结直肠癌切除术后第一个月内致瘤蛋白血浆Neuropilin-1的持续升高 Persistent elevation of plasma Neuropilin-1, a tumorigenic protein, during the first month after minimally invasive colorectal cancer resection Chandana S. K. Herath Mudiyanselage, Yi-Ru Chen, Neil Mitra, Monica S. Naparst, Elizabeth Nilsson Sjolander, Vesna Cekic, Richard L. Whelan
- 6444 6444 ctDNA状态和多部位疾病负荷对阑尾癌或结直肠癌腹膜转移患者的预后影响 Prognostic impact of ctDNA status and multi-site disease burden for patients with peritoneal metastases from appendiceal or colorectal cancer Justin M. Bader, Kelsey LaBella, Nicole Aguirre, Kwasi Ofori, Princy Gupta, Anup Sharma, Huxley Smart, Alexander Kim, Robert Tseng, SANGWON YUN, Michael Cecchini, Raghav Sundar, Kiran Turaga
- 6445 6445 围手术期化疗对I-II期大细胞肺癌患者的临床获益：一项SEER数据库分析 Clinical benefits of perioperative chemotherapy for patients with stage I-II large cell lung cancer: A SEER database analysis Wongi Woo, Seoin Kim, Jongwoo Kim, Yoonjin Cha, Duk Hwan Moon, Sungsoo Lee, Young Kwang Chae
- 6446 6446 分子分型预测接受新辅助治疗后手术的胰腺癌患者的首个复发部位 Molecular profiling to predict the first site of recurrence in pancreatic cancer patients receiving neoadjuvant therapy followed by surgery Luigi Liguori, Marco Ventin, Liti Zhang, Erica Daniels, Giulia Cattaneo, Chiara Camillo, Maoyang Qi, Enrica Quattrocchi, Eduardo Tejeda-polanco, Arsen Osipov, Alexandra Gangi, Andrew Hendifar, Nicholas Nissen, Kambiz Kosari, Francesco Sabbatino, Cristina R. Ferrone
- 6447 6447 FOLFIRINOX加nivolumab促进交界可切除胰腺腺癌瘤内淋巴样聚集体产生浆细胞 FOLFIRINOX plus nivolumab promotes plasma cell production from intra-tumoral lymphoid aggregates in borderline resectable pancreatic adenocarcinoma Serena Zheng, Jason Link, Alykhan Premji, Michael Srienc, McKensie Hammons, Shineui Kim, David Dawson, Zev Wainberg, Timothy Donahue
-
- 6449 6449 腺苷阻断联合FOLFIRINOX化疗可增强小鼠和人胰腺腺癌引流淋巴结中滤泡辅助性T细胞的功能 Adenosine blockade combined with FOLFIRINOX chemotherapy enhances T follicular helper cell function in pancreatic adenocarcinoma draining lymph nodes from mice and humans Michael K. Srienc, Serena Zheng, Jason Link, Alykhan Premji, McKensie Hammons, Shineui Kim, Evan Abt, Caius G. Radu, David W. Dawson, Zev A. Wainberg, Timothy R. Donahue
